Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

CANCvsHELXETF Comparison

ETF 1
CANC

Tema Oncology ETF

This fund is part of
Tomorrow's Treatments
+0.45%
VS
ETF 2
HELX

Franklin Genomic Advancements ETF

This fund is part of
BioTech & Genomics
-0.06%

Tema Oncology ETF (CANC) belongs to the Tomorrow's Treatments segment. Franklin Genomic Advancements ETF (HELX) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Healthcare. CANC is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.5% for HELX. CANC is up 18.41% year-to-date (YTD) with +$52M in YTD flows. HELX performs worse with 7.06% YTD performance, and +$6M in YTD flows. Run a side-by-side ETF comparison of CANC and HELX below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

CANC vs HELX performance and flow charts

Performance

-4.0-2.00.02.04.0%Jun 29Jul 7Jul 14Jul 21

Cumulative Flows

-8 M-6 M-4 M-2 M0 M2 M4 MJun 29Jul 7Jul 14Jul 21

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/27/2026
1M3MYTD1Y3Y5Y
Perf.
CANC
HELX
-0.28%-2.99%
+8.61%+15.45%
+18.41%+7.06%
+53.77%+38.11%
n/a+25.32%
n/a-23.15%
Flows
CANC
HELX
-$2M+$4M
+$3M+$4M
+$52M+$6M
+$76M+$10M
-+$13M
-+$18M
Volatility and drawdown
3M1Y3Y5Y
Volatility
CANC
HELX
+23.01%+24.88%
+22.71%+21.77%
n/a+20.98%
n/a+23.61%
Max drawdown
CANC
HELX
-5.93%-6.59%
-9.20%-17.89%
n/a-29.16%
n/a-58.50%
Max drawdown duration
CANC
HELX
47d18d
67d206d
n/a458d
n/a1784d
Trading data

Create an account to view trading data

Join for free
CANC
HELX
Last sale
7/28/2026 at 1:30 PM
$41.18
$39.13
Previous close
07/27/2026
$41.10
$38.86
Consolidated volume
07/27/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Advertisement
Main metrics
Last update 7/28/2026 at 1:30 PM
Live
Closed
CANC
HELX
Last price
$41.18
$39.13
1D performance
+0.20%
+0.70%
AuM$195.62 M$29.14 M
E/R0.99%0.5%
Characteristics
CANC
HELX
Management strategyActiveActive
ProviderTemaFranklin Templeton
Benchmark--
N° of holdings5661
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateAugust 15, 2023February 25, 2020
ESGNoNo
Advertisement
Exposure

Countries

CANC
USA
80.59%
Switzerland
9.85%
Other
9.56%
HELX
USA
87.84%
Other
12.16%

Sectors

CANC
Healthcare
99.28%
Other
0.72%
HELX
Healthcare
96.75%
Other
3.25%
Advertisement

Diversification

CANC

Total weight of top 15 holdings out of 15

55.76%
HELX

Total weight of top 15 holdings out of 15

59.93%

Top 15 holdings

Data as of June 30, 2026
CANC
Revolution Medicines, Inc.
6.32%
Eli Lilly & Co.
5.24%
Cogent Biosciences, Inc.
4.94%
Novartis AG
4.19%
Roche Holding AG
3.93%
Legend Biotech Corp.
3.70%
Merck & Co., Inc.
3.66%
Bristol Myers Squibb Co.
3.33%
AstraZeneca PLC
3.15%
Johnson & Johnson
3.09%
AbbVie, Inc.
3.08%
Immunome, Inc.
2.87%
Exelixis, Inc.
2.85%
Nuvalent, Inc.
2.73%
IDEAYA Biosciences, Inc.
2.68%
HELX
Guardant Health, Inc.
9.30%
Natera, Inc.
7.40%
Krystal Biotech, Inc.
6.51%
Ligand Pharmaceuticals, Inc.
4.56%
Adaptive Biotechnologies Corp.
4.01%
United Therapeutics Corp.
3.61%
BridgeBio Pharma, Inc.
3.39%
Eli Lilly & Co.
3.05%
Twist Bioscience Corp.
2.84%
Vertex Pharmaceuticals, Inc.
2.79%
Travere Therapeutics, Inc.
2.76%
AstraZeneca PLC
2.76%
Insmed, Inc.
2.43%
Corteva, Inc.
2.26%
SAMSUNG BIOLOGICS Co., Ltd.
2.26%
Frequently asked questions about CANC and HELX

How have the CANC and HELX ETFs performed in 2026?

As of July 27, 2026, CANC is up 18.41% year-to-date (YTD), while HELX has returned 7.06%. That puts CANC better performer ahead so far this year.

Which ETF is attracting more investor money: CANC or HELX?

Year-to-date, the CANC ETF saw +$52M in flows, compared to +$6M for HELX.

Which ETF is more volatile: CANC or HELX?

Over the past year, CANC had a volatility of 22.71%, while HELX experienced 21.77%.

Which ETF is bigger: CANC or HELX?

As of July 27, 2026, CANC holds $195.62 M in assets under management (AUM), while HELX manages $29.14 M.

What sectors do the CANC and HELX ETFs invest in?

CANC leans toward sectors like Healthcare. Meanwhile, HELX focuses on Healthcare.

What are the top holdings of the CANC ETF and HELX ETF?

CANC top holdings include Revolution Medicines, Inc., Eli Lilly & Co. and Cogent Biosciences, Inc.. HELX holds in its top three: Guardant Health, Inc., Natera, Inc. and Krystal Biotech, Inc..

Which ETF is more diversified: CANC or HELX?

CANC holds 56 securities with 55.76% of its assets in the top 15. HELX has 61 securities and a top 15 weight of 59.93%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder